4-Oxobenzo[D]1,2,3-Triazin-Pyridinium-Phenylacetamide Derivatives As New Anti-Alzheimer Agents: Design, Synthesis, in Vitro Evaluation, Molecular Modeling, and Molecular Dynamic Study

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share this content! By

4-Oxobenzo[D]1,2,3-Triazin-Pyridinium-Phenylacetamide Derivatives As New Anti-Alzheimer Agents: Design, Synthesis, in Vitro Evaluation, Molecular Modeling, and Molecular Dynamic Study Publisher

Hosseini F¹ ; Mohammadikhanaposhtani M² ; Azizian H³ ; Ramazani A¹ ; Tehrani MB⁴ ; Nadri H⁵ ; Larijani B⁶ ; Biglar M⁶ ; Adibi H⁶ ; Mahdavi M⁶

Source: Structural Chemistry Published:2020

Abstract

A new series of 4-oxobenzo[d]1,2,3-triazin-pyridinium-phenylacetamide hybrids 8a–p was designed, synthesized, and screened as the potential cholinesterase inhibitors against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). Obtained anti-cholinesterase activities demonstrated that all the title compounds exhibited excellent inhibition against BuChE and moderate inhibitory activity toward AChE in comparison to standard cholinesterase inhibitor donepezil. For example, compound 8e exhibited about 49-fold higher inhibitory activity than donepezil (IC50 = 3.2 ± 0.3 μM) against BuChE. This compound inhibited BuChE via a mixed-type inhibition mode. This finding demonstrated that compound 8e in addition to catalytic anionic site (CAS) can also interact with the peripheral anionic site (PAS) of BuChE. Molecular modeling and molecular dynamic studies were also performed on synthesized compounds. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.

Related Docs

View other Related Docs

1. Design, Synthesis, Molecular Docking, and Cholinesterase Inhibitory Potential of Phthalimide-Dithiocarbamate Hybrids As New Agents for Treatment of Alzheimer's Disease, Chemistry and Biodiversity (2019)

2. Novel Tacrine-1,2,3-Triazole Hybrids: In Vitro, in Vivo Biological Evaluation and Docking Study of Cholinesterase Inhibitors, European Journal of Medicinal Chemistry (2017)

3. Novel Tacrine-Coumarin Hybrids Linked to 1,2,3-Triazole As Anti-Alzheimer's Compounds: In Vitro and in Vivo Biological Evaluation and Docking Study, Bioorganic Chemistry (2019)

Experts (# of related papers)

View all Related Experts

Mohammad Mahdavi (14)

Tahmineh Akbarzadeh (11)

Other Related Docs

4. Design and Synthesis of Multi-Target Directed 1,2,3-Triazole-Dimethylaminoacryloyl-Chromenone Derivatives With Potential Use in Alzheimer's Disease, BMC Chemistry (2020)

5. Design and Synthesis of Benzodiazepine-1,2,3-Triazole Hybrid Derivatives As Selective Butyrylcholinesterase Inhibitors, Molecular Diversity (2020)

6. Design and Synthesis of Novel Anti-Alzheimer's Agents: Acridine-Chromenone and Quinoline-Chromenone Hybrids, Bioorganic Chemistry (2016)

7. Cholinesterase Inhibition Activity and Docking Simulation Study of Coumarin Mannich Base Derivatives, Journal of Sciences# Islamic Republic of Iran (2019)

8. Anticholinesterase Activity of Cinnamic Acids Derivatives: In Vitro, in Vivo Biological Evaluation, and Docking Study, Letters in Drug Design and Discovery (2020)

9. Synthesis, Docking Study and Neuroprotective Effects of Some Novel Pyrano[3,2-C]Chromene Derivatives Bearing Morpholine/Phenylpiperazine Moiety, Bioorganic and Medicinal Chemistry (2017)

10. Design and Synthesis of Novel Coumarin-Pyridinium Hybrids: In Vitro Cholinesterase Inhibitory Activity, Bioorganic Chemistry (2018)

11. Design and Synthesis of Novel Arylisoxazole-Chromenone Carboxamides: Investigation of Biological Activities Associated With Alzheimer's Disease, Chemistry and Biodiversity (2020)

12. Design and Synthesis of 2,4-Dioxochroman-Pyridinium-Phenylacetamide Derivatives As New Anti-Alzheimer Agents: In Vitro and in Silico Studies, Journal of the Chinese Chemical Society (2020)

13. Synthesis and Cholinesterase Inhibitory Activity of New 2-Benzofuran Carboxamide-Benzylpyridinum Salts, Bioorganic Chemistry (2018)

14. Novel 1,2,4-Oxadiazole Derivatives As Selective Butyrylcholinesterase Inhibitors: Design, Synthesis, and Biological Evaluation, EXCLI Journal (2021)

15. Novel Tetrahydrocarbazole Benzyl Pyridine Hybrids As Potent and Selective Butryl Cholinesterase Inhibitors With Neuroprotective and Β-Secretase Inhibition Activities, European Journal of Medicinal Chemistry (2018)

16. Design, Synthesis, and Cholinesterase Inhibition Assay of Coumarin-3-Carboxamide-N-Morpholine Hybrids As New Anti-Alzheimer Agents, Chemistry and Biodiversity (2019)

17. New Imidazo[1,2-A]Pyridin-2-Yl Derivatives As Ache, Bche, and Lox Inhibitors; Design, Synthesis, and Biological Evaluation, Letters in Drug Design and Discovery (2023)

18. Novel Tacrine-Based Acetylcholinesterase Inhibitors As Potential Agents for the Treatment of Alzheimer’S Disease: Quinolotacrine Hybrids, Molecular Diversity (2022)

19. Chemical Composition, Cholinesterase, and Α-Glucosidase Inhibitory Activity of the Essential Oils of Some Iranian Native Salvia Species, BMC Complementary Medicine and Therapies (2023)

20. Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs As Potent Anti-Alzheimer's Agents, Chemistry and Biodiversity (2019)

Style	Citing Format
MLA	Hosseini F, et al.. "4-Oxobenzo[D]1,2,3-Triazin-Pyridinium-Phenylacetamide Derivatives As New Anti-Alzheimer Agents: Design, Synthesis, in Vitro Evaluation, Molecular Modeling, and Molecular Dynamic Study." Structural Chemistry, vol. 31, no. 3, 2020, pp. 999-1012.
APA	Hosseini F, Mohammadikhanaposhtani M, Azizian H, Ramazani A, Tehrani MB, Nadri H, Larijani B, Biglar M, Adibi H, Mahdavi M (2020). 4-Oxobenzo[D]1,2,3-Triazin-Pyridinium-Phenylacetamide Derivatives As New Anti-Alzheimer Agents: Design, Synthesis, in Vitro Evaluation, Molecular Modeling, and Molecular Dynamic Study. Structural Chemistry, 31(3), 999-1012.
Chicago	Hosseini F, Mohammadikhanaposhtani M, Azizian H, Ramazani A, Tehrani MB, Nadri H, Larijani B, Biglar M, Adibi H, Mahdavi M. "4-Oxobenzo[D]1,2,3-Triazin-Pyridinium-Phenylacetamide Derivatives As New Anti-Alzheimer Agents: Design, Synthesis, in Vitro Evaluation, Molecular Modeling, and Molecular Dynamic Study." Structural Chemistry 31, no. 3 (2020): 999-1012.
Harvard	Hosseini F et al. (2020) '4-Oxobenzo[D]1,2,3-Triazin-Pyridinium-Phenylacetamide Derivatives As New Anti-Alzheimer Agents: Design, Synthesis, in Vitro Evaluation, Molecular Modeling, and Molecular Dynamic Study', Structural Chemistry, 31(3), pp. 999-1012.
Vancouver	Hosseini F, Mohammadikhanaposhtani M, Azizian H, Ramazani A, Tehrani MB, Nadri H, et al.. 4-Oxobenzo[D]1,2,3-Triazin-Pyridinium-Phenylacetamide Derivatives As New Anti-Alzheimer Agents: Design, Synthesis, in Vitro Evaluation, Molecular Modeling, and Molecular Dynamic Study. Structural Chemistry. 2020;31(3):999-1012.
BibTex	@article{ author = {Hosseini F and Mohammadikhanaposhtani M and Azizian H and Ramazani A and Tehrani MB and Nadri H and Larijani B and Biglar M and Adibi H and Mahdavi M}, title = {4-Oxobenzo[D]1,2,3-Triazin-Pyridinium-Phenylacetamide Derivatives As New Anti-Alzheimer Agents: Design, Synthesis, in Vitro Evaluation, Molecular Modeling, and Molecular Dynamic Study}, journal = {Structural Chemistry}, volume = {31}, number = {3}, pages = {999-1012}, year = {2020} }
RIS	TY - JOUR AU - Hosseini F AU - Mohammadikhanaposhtani M AU - Azizian H AU - Ramazani A AU - Tehrani MB AU - Nadri H AU - Larijani B AU - Biglar M AU - Adibi H AU - Mahdavi M TI - 4-Oxobenzo[D]1,2,3-Triazin-Pyridinium-Phenylacetamide Derivatives As New Anti-Alzheimer Agents: Design, Synthesis, in Vitro Evaluation, Molecular Modeling, and Molecular Dynamic Study JO - Structural Chemistry VL - 31 IS - 3 SP - 999 EP - 1012 PY - 2020 ER -

Science Communicator Platform

Authors

Abstract